Adherence to evidence-based therapies after discharge for acute coronary syndromes: an ongoing prospective, observational study

The American Journal of Medicine
Kim A EaglePhilippe Gabriel Steg

Abstract

To determine the rates of patient adherence to key evidence-based therapies at 6 months after hospital discharge for an acute coronary syndrome. In this nonrandomized, prospective, multinational, multicenter study, adherence to aspirin, beta-blockers, statins, or angiotensin-converting enzyme (ACE) inhibitors 6 months after discharge for myocardial infarction or unstable angina was assessed in 21,408 patients aged 18 years or older. Patients were enrolled at 104 tertiary and community hospitals representing a broad range of care facilities and practice settings (e.g., teaching vs. nonteaching). Of 13,830 patients, discontinuation of therapy was observed at 6-month follow-up in 8% of those taking aspirin on discharge, 12% of those taking beta-blockers, 20% of those taking ACE inhibitors, and 13% of those taking statins. In a multivariate analysis, adherence to beta-blocker therapy was higher in patients with a myocardial infarction (odds ratio [OR] = 1.25; 95% confidence interval [CI]: 1.06 to 1.47), hypertension (OR = 1.33; 95% CI: 1.15 to 1.54), ST-segment elevation myocardial infarction (OR = 1.33; 95% CI: 1.11 to 1.61), or non-ST-segment elevation myocardial infarction (OR = 1.25; 95% CI: 1.08 to 1.45). Aspirin adherence was...Continue Reading

References

Feb 1, 1984·Annals of Internal Medicine·S A ErakerM H Becker
Jan 8, 1997·JAMA : the Journal of the American Medical Association·S B SoumeraiL Goldman
Apr 29, 1998·Archives of Internal Medicine·R C ZiegelsteinJ A Fauerbach
May 26, 1998·JAMA : the Journal of the American Medical Association·J AvornJ LeLorier
Jul 1, 1997·Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine·L E BurkeM N Hill
Dec 5, 1998·The New England Journal of Medicine·UNKNOWN Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group
Feb 22, 2001·The American Journal of Medicine·P A Heidenreich, M McClellan
Dec 6, 2001·Current Hypertension Reports·R Düsing
Jul 23, 2002·JAMA : the Journal of the American Medical Association·Cynthia A JackeviciusJack V Tu

❮ Previous
Next ❯

Citations

Jan 11, 2007·European Journal of Clinical Pharmacology·Annika BardelKurt Svärdsudd
May 5, 2007·Heart Failure Reviews·Paul J Hauptman
Jan 12, 2011·Journal of Clinical Psychology in Medical Settings·Kristen FarrellMichael H Antoni
Jan 4, 2013·International Journal of Clinical Pharmacy·Yaman KassabHadeer AbdulRazzaq
Oct 9, 2007·Journal of General Internal Medicine·Ayse AkincigilStephen Crystal
Aug 27, 2009·The Journal of Cardiovascular Nursing·Linda GaravaliaCarole Decker
Aug 27, 2009·The Journal of Cardiovascular Nursing·Victoria Vaughan Dickson
Aug 11, 2006·Journal of General Internal Medicine·Ian M KronishKarina W Davidson
Aug 19, 2011·The Journal of Pharmacology and Experimental Therapeutics·Marcus M Reidenberg
Feb 24, 2006·Cerebrovascular Diseases·Aida LagoUNKNOWN Stroke Project (Cerebrovascular Diseases Group of the Spanish Neurological Society)
Dec 25, 2009·Circulation. Cardiovascular Quality and Outcomes·Jeffrey S BergerSylvia Wassertheil-Smoller
Jun 24, 2010·BMC Public Health·Toomas MarandiTiia Ainla
Oct 26, 2006·BMC Health Services Research·Manfred StommelJoseph C Gardiner
Dec 15, 2005·Thrombosis Journal·Enrique P GurfinkelFrederick Anderson
Aug 13, 2010·The Annals of Pharmacotherapy·Devin M MannIan Kronish
Dec 1, 2007·Clinical Interventions in Aging·Julia L Newton
Jun 16, 2006·Applied Health Economics and Health Policy·Richard F HellerRichard D Smith
Mar 26, 2010·American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions·Johan HerlitzJørgen Naesdal
Apr 24, 2012·EuroIntervention : Journal of EuroPCR in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology·Philippe LatryThierry Couffinhal
Jul 5, 2012·Women's Health·Jean McSweeneySeongkum Heo
Dec 4, 2009·Expert Opinion on Pharmacotherapy·T R BatesG F Watts
Nov 13, 2004·Current Medical Research and Opinion·Stella S DaskalopoulouDimitri P Mikhailidis
Oct 27, 2015·Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine·Annie Selina Kozlowski JonesElizabeth Broadbent
Jun 14, 2008·European Journal of Internal Medicine·Alan B JotkowitzAvi Porath
Sep 1, 2015·Revista Española De Cardiología·José López-SendónUNKNOWN INCARDIO Task Force (Indicadores de Calidad en Unidades Asistenciales del Área del Corazón) joint Sociedad Española de Cardi
Nov 17, 2015·International Journal of Cardiology·Cuneyt KocasMurat Ersanli
Jun 18, 2010·Cardiovascular Therapeutics·Jesse DawsonMatthew R Walters
Sep 26, 2012·Journal of the American Geriatrics Society·Ilene H ZuckermanBruce Stuart
Dec 5, 2009·Journal of the American Academy of Nurse Practitioners·Andrea Brassard
May 12, 2010·International Journal of Clinical Practice·S Connolly
Apr 24, 2012·American Heart Journal·Sara Bristol CalvertNancy M Allen LaPointe
Oct 19, 2006·International Journal of Cardiology·Enrique P GurfinkelUNKNOWN GRACE Investigators
Dec 8, 2006·Expert Opinion on Pharmacotherapy·Gregg C Fonarow

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.